AU2007300221A8
(en )
2009-05-14
Stabilized antibody formulations and uses thereof
EP2436696B8
(en )
2017-12-13
Anti-beta-amyloid antibody and uses thereof
IL196397A0
(en )
2011-08-01
Prlr-specific antibody and uses thereof
IL195658A0
(en )
2011-08-01
Anti-nkg2a antibodies and uses thereof
EP1987067A4
(en )
2012-01-25
Antibody formulation
AU2006339063A8
(en )
2008-07-31
Macro-diacrylates and macro-polyacrylates
HK1133574A
(en )
2010-04-01
Stabilized antibody formulations and uses thereof
HK1130070A
(en )
2009-12-18
Ephb3-specific antibody and uses thereof
HK1118561A
(en )
2009-02-13
Antibody formulation
HK1113165A
(en )
2008-09-26
Compositions comprising cross-species-specific antibodies and uses thereof
HK1127361A
(en )
2009-09-25
Anti-igf-ir antibodies and uses thereof
HK1134652A
(en )
2010-05-07
Compounds and uses thereof
HK1136978A
(en )
2010-07-16
Compounds and uses thereof
HK1136472A
(en )
2010-07-02
Compounds and uses thereof
HK1136509A
(en )
2010-07-02
Compounds and uses thereof
HK1109637A
(en )
2008-06-13
Irta-2 antibodies and their uses
HK1134440A
(en )
2010-04-30
Stable antibody formulations
AU2013206191B2
(en )
2016-05-12
Thioninium compounds and their use
AU2006904073A0
(en )
2006-08-10
Biomedicinals and their uses
HK1124765A
(en )
2009-07-24
Protein formulations
AU2006906220A0
(en )
2006-11-23
Arsenoxide compounds and use thereof
HK1134496A
(en )
2010-04-30
ANTIBODIES DIRECTED TO ALPHAVß6 AND USES THEREOF
AU2005902195A0
(en )
2005-05-12
Composition and uses thereof
AU2006903659A0
(en )
2006-07-20
Antibodies and related methods
HK1137179A
(en )
2010-07-23
Anti-robo4 antibodies and uses therefor